These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2360450)

  • 1. Penetration of enoxacin into middle ear effusion.
    Sundberg L; Edén T
    Acta Otolaryngol; 1990; 109(5-6):438-43. PubMed ID: 2360450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of cefprozil to middle ear effusion in children with chronic otitis media with effusion.
    Jang CH; Park SY
    Int J Pediatr Otorhinolaryngol; 2003 Sep; 67(9):965-8. PubMed ID: 12907051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections.
    Marchbanks CR; Mikolich DJ; Mayer KH; Zinner SH; Dudley MN
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1966-72. PubMed ID: 2291662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo diffusion of enoxacin in healthy renal and adenomatous prostate tissue in man.
    Charton M; Timbal Y
    Eur Urol; 1990; 17(3):252-6. PubMed ID: 1693576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enoxacin concentration in human prostatic tissue after 3-day administration].
    Morita M; Kato M; Kuji S; Hasuda A
    Hinyokika Kiyo; 1988 Jul; 34(7):1293-6. PubMed ID: 2459943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the correlation of substance P in middle ear effusion and clinical presentation in secretory otitis media].
    Wang Gf
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Nov; 19(22):1026-8. PubMed ID: 16463765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring antibiotic levels in otitis media.
    Thoroddsen E
    Ear Nose Throat J; 1998 Jun; 77(6 Suppl):13-5. PubMed ID: 9674329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of enoxacin and its oxometabolite after multiple oral dosing and penetration into prostatic tissue.
    Hamel B; Mottet N; Audran M; Costa P; Bressolle F
    J Antimicrob Chemother; 2000 Dec; 46(6):993-6. PubMed ID: 11102420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nitric oxide and cytokines in otitis media with effusion].
    Lin G; Huang W; Jiang H; Wang J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Feb; 35(1):23-5. PubMed ID: 12768683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic steroid for chronic otitis media with effusion in children.
    Mandel EM; Casselbrant ML; Rockette HE; Fireman P; Kurs-Lasky M; Bluestone CD
    Pediatrics; 2002 Dec; 110(6):1071-80. PubMed ID: 12456902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient].
    Tanaka K; Nakano Y; Ono Y; Hirabayashi S; Yamada S
    Hinyokika Kiyo; 1988 Nov; 34(11):2067-9. PubMed ID: 3242374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic profile of miocamycin in middle ear fluid and mucosa.
    Fraschini F; Scaglione F; Falchi M; Nebuloni R; Zampella K; Saudelli M; De Luca M; Casini A; Pintucci GP
    Acta Otolaryngol; 1991; 111(4):756-61. PubMed ID: 1950539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between the content of fibrinogen in middle ear effusion and the effect of treatment on secretory otitis media].
    Chen XH; Wu X; Huang B
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Aug; 41(8):566-9. PubMed ID: 17039794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of platelet activating factor in middle ear effusion of patients with secretory oitits media].
    Chen L; Huang Y; You J; Wang J; Chen Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Oct; 17(10):607-8. PubMed ID: 14727433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on enoxacin concentration in human prostatic tissue].
    Kitamura Y; Kataumi Z; Nakamura T; Takeda H
    Hinyokika Kiyo; 1990 Jan; 36(1):101-2. PubMed ID: 1689927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.
    Iino Y; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Kanazawa H; Yoshida N
    Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Superoxide dismutase and cytokines in otitis media with effusion].
    Dong W; Li Z; Zhou S
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):452-4. PubMed ID: 12541690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brodimoprim concentrations in bronchial mucosa, bronchial secretions and middle ear effusions.
    Scaglione F; Cogo R; Pintucci JP; Demartini G; Dugnani S; Maccarinelli G; Fraschini F
    J Chemother; 1993 Dec; 5(6):490-3. PubMed ID: 8195843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of tissue penetration and clinical efficacy of enoxacin in skin and skin structure infections and in osteomyelitis.
    Pankey GA
    Clin Pharmacokinet; 1989; 16 Suppl 1():46-51. PubMed ID: 2653695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue penetration and clinical efficacy of enoxacin in respiratory tract infections.
    Wood MJ
    Clin Pharmacokinet; 1989; 16 Suppl 1():38-45. PubMed ID: 2653694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.